69 filings
8-K
ARGS
Argos Therapeutics Inc
3 May 19
Changes in Registrant's Certifying Accountant
4:10pm
8-K
ARGS
Argos Therapeutics Inc
3 Dec 18
Bankruptcy or Receivership
8:01am
8-K
ARGS
Argos Therapeutics Inc
20 Jul 18
Departure of Directors or Certain Officers
4:30pm
8-K
ARGS
Argos Therapeutics Inc
24 Apr 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
ARGS
Argos Therapeutics Inc
19 Apr 18
Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives
12:00am
8-K
onmjy6
2 Apr 18
Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
12:00am
8-K
eq1pscf f9
7 Mar 18
Other Events
12:00am
8-K
wutf67io2m
16 Feb 18
Other Events
12:00am
8-K
mpj1r zutibwa
5 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K/A
31f3ovgeg9hm795
30 Jan 18
Financial Statements and Exhibits
12:00am
8-K
9xz8qfa
18 Jan 18
Material Modifications to Rights of Security Holders
12:00am
8-K
chcx abzzzp
8 Jan 18
Other Events
12:00am
8-K
xx6syu tg
28 Nov 17
Argos Provides Financial Update
12:00am
8-K
plvrt
9 Nov 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
20nubk4bn5 dlikt0obw
6 Nov 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
s1pybln6cvn0 hwwn
27 Oct 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
x0bjm20x2n244o
26 Sep 17
Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors
12:00am
8-K
zn1em3focehihthn
25 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
9s22 mnky0iz6813j
12 Sep 17
Argos Therapeutics Reports on Interim Analysis of Phase 3 ADAPT Trial Presented at ESMO 2017 Congress
12:00am
8-K
l9if6sqezug2om596i
5 Sep 17
Departure of Directors or Certain Officers
12:00am